About CoAptus Medical
CoAptus Medical is a company based in Redmond (United States) founded in 2003 by Joseph E. Eichinger. It operates as a B2B. CoAptus Medical has raised $3 million across 1 funding round. The company has 40 employees as of December 31, 2022. CoAptus Medical operates in a competitive market with competitors including Xeltis, PECA Labs, Occlutech, Endonovo Therapeutics and Coherex, among others.
- Headquarter Redmond, United States
- Employees 40 as on 31 Dec, 2022
- Founders Joseph E. Eichinger
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Cybersaint, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3 M (USD)
in 1 rounds
-
Latest Funding Round
$3 M (USD), Series A
May 18, 2009
-
Investors
Not available
-
Employee Count
40
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CoAptus Medical
CoAptus Medical has successfully raised a total of $3M through 1 strategic funding round. The most recent funding activity was a Series A round of $3 million completed in May 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by CoAptus Medical
Investment portfolio details for CoAptus Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CoAptus Medical
Detailed financials for CoAptus Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Coaptus Medical Comparisons
Peer comparison for CoAptus Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CoAptus Medical
CoAptus Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Xeltis, PECA Labs, Occlutech, Endonovo Therapeutics and Coherex, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of bioabsorbable synthetic heart valves and vascular grafts
|
|
| Locked | Locked | Locked |
Pediatric cardiac surgical devices are developed for congenital heart defects.
|
|
| Locked | Locked | Locked |
Provider of minimally invasive cardiac devices for congenital heart defects, stroke prevention and heart failure
|
|
| Locked | Locked | Locked |
Bioelectronic devices are developed for regenerative medicine therapies.
|
|
| Locked | Locked | Locked |
Structural heart disease conditions are addressed with implant devices.
|
Detailed competitors of CoAptus Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Coaptus Medical
Complete news archive for CoAptus Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CoAptus Medical
CoAptus Medical was founded in 2003 and raised its 1st funding round 6 years after it was founded.
CoAptus Medical is headquartered in Redmond, United States. It is registered at Redmond, Washington, United States.
CoAptus Medical is a funded company, having raised a total of $3M across 1 funding round to date.
As of Dec 31, 2022, the latest employee count at CoAptus Medical is 40.
CoAptus Medical operates with a B2B model, focusing on providing healthcare solutions, developing medical devices, cardiovascular, and non-implant therapeutics. Develops non-implant therapeutics for treating patent foramen ovale, a structural heart defect. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
CoAptus Medical's top competitors include Xeltis, PECA Labs and Endonovo Therapeutics.